ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0384

Hip Fracture Hospitalization Trends in Osteoporotic Patients (2016–2022): National Data Insights

Simran Bhimani1, Anand Reddy Maligireddy2, Sameer Bhimani3 and Birju Bhatt4, 1The Wright Center for graduate medical education, Scranton, PA, 2The Wright Center GME, Scarnton, PA, 3The Wright Center for GME, scranton, PA, 4Solara Health NJ, New Jersey, NJ

Meeting: ACR Convergence 2025

Keywords: osteoporosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0357–0386) Patient Outcomes, Preferences, & Attitudes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Hip fractures in patients with osteoporosis are a major contributor to morbidity, mortality, and healthcare costs. While classically associated with the oldest patients, emerging trends suggest that younger elderly adults may now bear a growing share of the burden. We evaluated age-stratified trends in hip fracture hospitalizations and in-hospital mortality among osteoporotic adults in the United States.

Methods: We conducted a retrospective cohort study using the National Readmissions Database (NRD) from 2016 to 2022. We included adult patients hospitalized with osteoporosis and identified those with a primary discharge diagnosis of hip fracture using ICD-10 codes. Patients were stratified into age groups: < 50, 50–59, 60–69, 70–79, 80–89, and ≥90 years. Survey-weighted logistic regression was used to evaluate temporal trends in hip fracture hospitalizations and in-hospital mortality, comparing 2022 to 2016 within each age group.

Results: Among 5,040,169 weighted osteoporosis-related hospitalizations, 392,615 (7.8%) were for hip fractures. The 70–79 age group showed the most significant increase in hip fracture hospitalizations, rising from 22.5% in 2016 to 28.6% in 2022. Odds of hip fracture rose by 13% in this group (OR: 1.13, 95% CI: 1.06–1.20, p < 0.001). The 60–69 group also demonstrated a significant increase (OR: 1.12, p = 0.006) Figure 1. Despite these increases, in-hospital mortality rates remained unchanged across all groups Figure 2.

Conclusion: From 2016 to 2022, adults aged 70–79 with osteoporosis experienced a significant rise in hip fracture hospitalizations without increased in-hospital mortality, reflecting improved acute care. Proactive screening, earlier risk assessment, and fall prevention efforts targeting adults in their 60s and 70s may be critical in curbing the growing hospitalization burden in this increasingly vulnerable population Figure 3.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: S. Bhimani: None; A. Maligireddy: None; S. Bhimani: None; B. Bhatt: None.

To cite this abstract in AMA style:

Bhimani S, Maligireddy A, Bhimani S, Bhatt B. Hip Fracture Hospitalization Trends in Osteoporotic Patients (2016–2022): National Data Insights [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/hip-fracture-hospitalization-trends-in-osteoporotic-patients-2016-2022-national-data-insights/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hip-fracture-hospitalization-trends-in-osteoporotic-patients-2016-2022-national-data-insights/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology